GlassScriptPhysician profile
Rene'E D Romero
NPI 1740875475
$1,728.94
in general payments reported to CMS, 2019-2025
23 companies · $825 in 2025
The $825 reported for 2025 was more than what 84% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $13.89 · 2024: $890 · 2025: $825.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,729.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,728.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $298.97 | 2024-2025 | Watchman Access System, Opticross |
| Philips North America LLC | $251.98 | 2024-2025 | Extended Holter, (5044) Mcot, Mcot |
| Novo Nordisk INC | $179.23 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $165.04 | 2025 | Repatha |
| Atricure, INC. | $157.37 | 2024-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| E.R. Squibb & Sons, L.L.C. | $111.96 | 2024 | Eliquis |
| Edwards Lifesciences Corporation | $96.39 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $74.93 | 2024-2025 | Lifevest |
| Abiomed | $61.39 | 2024 | Impella |
| Cardiva Medical, INC. | $61.39 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Optowire |
| Astrazeneca Pharmaceuticals LP | $41.09 | 2025 | Wainua, Lokelma |
| Cvrx, INC. | $39.43 | 2025 | Barostim Neo System |
| Kiniksa Pharmaceuticals International, Plc | $27.57 | 2024 | Arcalyst |
| Pfizer INC. | $27.15 | 2024 | |
| Bridgebio Pharma, INC. | $22.74 | 2025 | Attruby |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $21.09 | 2025 | Carto 3 |
| Novartis Pharmaceuticals Corporation | $17.62 | 2025 | |
| Heartflow, INC. | $15.42 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.93 | 2024 | |
| Merck Sharp & Dohme LLC | $13.45 | 2024 | Verquvo |
| Scpharmaceuticals INC. | $13.21 | 2024 | |
| Altathera Pharmaceuticals LLC | $9.59 | 2024 | Sotalol Hydrochloride |
| Vivaquant INC, Dba Rhythm Express | $8.00 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rene'E Romero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.